Kobayashi Pharmaceutical Co. Ltd
Research Kobayashi Pharmaceutical Co. Ltd (KOY) on Bullrun: market cap EUR 2.13B, P/E 102.2, dividend yield 1.9%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerKOY
- ExchangeF
- CountryJapan
- SectorConsumer Defensive
- IndustryHousehold & Personal Products
- CurrencyEUR
- Market capEUR 2.13B
- P/E102.2
- Dividend yield1.9%
- Financial periodQ4 2024
- RevenueJPY 51.14B
- Net incomeJPY 4.72B
- Gross margin48.7%
Valuation Snapshot
latest market cap is EUR 2.13B; P/E is 102.2; dividend yield is 1.9%.
Peer valuation comparison
Latest P/E is 102.22x versus a Consumer Defensive sector median of 17.41x (487.1% above).
Latest dividend yield is 1.92% versus a Consumer Defensive sector median of 3.04% (36.8% below).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-06-18 | EUR 2.13B | 102.2 | 2.0% | 0.57 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.57 EUR, yield 1.9%.
About Kobayashi Pharmaceutical Co. Ltd
Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells OTC pharmaceuticals, guasi-drugs, deodorizing air fresheners, and sanitary products in Japan, the United States, Southeast Asia, and internationally. The company offers Ammeltz, an anti-inflammatory pain relief medicine; Dent, an effervescent denture cleaning agent; Ekitai Bluelet Okudake, a toilet bowl cleaner; Naicitol, a Chinese herbal medicine that promotes the breakdown and metabolism of fat;
Related stock research
Other Consumer Defensive stocks
Frequently asked questions
What is Kobayashi Pharmaceutical Co. Ltd's market cap?
Kobayashi Pharmaceutical Co. Ltd's market capitalization is EUR 2.13B.
What is Kobayashi Pharmaceutical Co. Ltd's P/E ratio?
Kobayashi Pharmaceutical Co. Ltd's price-to-earnings (P/E) ratio is 102.2.
Does Kobayashi Pharmaceutical Co. Ltd pay a dividend?
Kobayashi Pharmaceutical Co. Ltd has a dividend yield of 1.9%.
What does Kobayashi Pharmaceutical Co. Ltd do?
Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells OTC pharmaceuticals, guasi-drugs, deodorizing air fresheners, and sanitary products in Japan, the United States, Southeast Asia, and internationally.